SecBot SecBot

CRON

Cronos Group Inc.
Nasdaq· Medicinal Chemicals & Botanical Products· Inc. A1· CIK 0001656472 Cannabis
$3.38 +0.07 (+2.11%)
Oct 27 4:00 PM ET · prev $3.31
Market cap
$1.2B
Small cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
🔒 Subscribers only
1 year
+35.7%
from $2.49 · Oct 28
30 days
−0.9%
from $3.41
52-week range
$2.30–3.55
−5% from high · low Nov 20
Avg volume 20D
906.8K
shares / day
Short interest
3.96M
≈1.1% of shares · +17.5%
Days to cover
4.8
at average volume
Insider net
$0
no open-market trades · since Mar 9
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 3 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BULLISH Cronos Group completed its acquisition of CanAdelaar B.V., the largest cannabis company in the Netherlands'…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Mar 9. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 9 added (0 new), 7 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better.

  • Short sellersBUILDING

    Short interest +17.5% to 3.96M shares. 4.8 days to cover, ≈1.1% of shares.

  • TrendRANGE

    3% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCDOUBLED950,985$2.6M
SUSQUEHANNA INTERNATIONAL GROUP, LLPTRIM756,075$2.1M
CITIGROUP INCADD249,077$688.2K
GROUP ONE TRADING LLCTRIM178,351$495.8K
BANK OF AMERICA CORP /DE/ADD157,631$438.2K
Nuveen, LLCTRIM137,738$380.6K
Quadrature Capital LtdTRIM93,986$261.3K
Zurcher Kantonalbank (Zurich Cantonalbank)DOUBLED87,123$240.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy2Buy6Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 13, 2026Zuanic & Associates
INITIATE
INITIATEOverweight

Insider ledger

Form 4
$0
open-market buys or sells · since Mar 9
DateInsiderTypeValue
Oct 16, 2026
Martens Christopher
General Manager
AWARD46,875 sh
Aug 6, 2026
ADLER JASON MARC
Director
AWARD48,859.93 sh
Aug 6, 2026
Garnick Murray R
Director
AWARD48,859.93 sh
Aug 6, 2026
RUDYK JAMES DANIEL
Director
AWARD48,859.93 sh
May 12, 2026
Buggy Shannon
See Remarks
EXERCISE20,622 sh
May 12, 2026
Buggy Shannon
See Remarks
TAX W/H$25.2K
May 12, 2026
Wagner Adam
See remarks
EXERCISE10,367 sh
May 12, 2026
Doucet Terrence Gregory Joseph
See Remarks
EXERCISE10,597 sh

Earnings setup

Estimates
$0.05
EPS estimate, this quarter
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.05$0.03–$0.07+34.3%$73.4M
Next Q$0.06$0.04–$0.07+34.9%$89.6M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
3,958,994
shares short
+17.5%
vs prior settlement
4.8
days to cover
≈1.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 Insider
Martens Christopher was granted 46,875 shares
General Manager
Oct 15, 2026 SEC
Cronos Group completed its acquisition of CanAdelaar B.V., the largest cannabis company in the Netherlands' adult-use…
8-K — Impact 6/10
Oct 15, 2026 Press
Cronos Group completed its acquisition of CanAdelaar, the largest cannabis company in the Netherlands' adult-use pilot…
Impact 6/10
Oct 15, 2026 M&A
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Norm
Aug 6, 2026 SEC
Cronos Group reported Q2 2026 results with record net revenue of $53.0M (+58% YoY), record gross profit of $28.5M…
8-K — Impact 7/10
Aug 6, 2026 SEC
Cronos Group reported Q2 2026 results with record net revenue of $53.0M (+58% YoY) and record gross profit of $28.5M…
PRESS-RELEASE — Impact 6/10
Aug 6, 2026 Insider
ADLER JASON MARC was granted 48,859.93 shares
Director
Aug 6, 2026 Insider
Garnick Murray R was granted 48,859.93 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 15, 2026
M&A
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA1 in 2026 and 2027 Establishes…
Sep 15, 2026
Press release
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Registration is now open for Cronos’ first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 Registration is…
Aug 6, 2026
Earnings
Cronos Group Reports 2026 Second Quarter Results
Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count
Jul 16, 2026
Earnings
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second…
Jun 30, 2026
Buyback
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis…

SecBot reports

7 filings · 2 press releases · 4 bullish · 0 bearish · 1 mixed · 2 neutral
All CRON filing & press-release reports (9)